# Feature Specification: Use of Artificial Intelligence in Medical Diagnostic Laboratories

**Feature Branch**: `ai-diagnostic-lab`
**Created**: 2025-12-21
**Status**: Draft
**Input**: User description: "Use of Artificial Intelligence in Medical Diagnostic Laboratories"

## User Scenarios & Testing *(mandatory)*

### User Story 1 - Access AI Diagnostic Literature (Priority: P1)

As a clinical pathologist, I want to access comprehensive information about AI applications in diagnostic laboratories so that I can understand how AI is transforming laboratory medicine and implement evidence-based practices in my workflow.

**Why this priority**: This is the foundational knowledge that clinical practitioners need to understand AI's role in diagnostic medicine.

**Independent Test**: Can be fully tested by accessing AI diagnostic literature and understanding the applications without any other features. Delivers core educational value to pathologists.

**Acceptance Scenarios**:

1. **Given** I am a clinical pathologist researching AI applications, **When** I access the AI diagnostic content, **Then** I can understand the current state of AI in diagnostic laboratories with evidence-based information.
2. **Given** I am looking for specific AI applications in my specialty, **When** I search for relevant content, **Then** I can find targeted information about AI applications in my field.

---

### User Story 2 - Evaluate AI System Validation (Priority: P2)

As a laboratory director, I want to evaluate the validation status of AI diagnostic systems so that I can make informed decisions about implementing AI tools in my diagnostic laboratory.

**Why this priority**: This addresses the critical need for validated AI systems in clinical settings where patient safety is paramount.

**Independent Test**: Can be fully tested by reviewing validation information for different AI diagnostic systems. Delivers value for decision-making in laboratory management.

**Acceptance Scenarios**:

1. **Given** I am considering an AI diagnostic system, **When** I review its validation information, **Then** I can see clear evidence of regulatory approval (FDA, CE, WHO) or peer-reviewed clinical validation studies.
2. **Given** I need to compare multiple AI systems, **When** I access their validation data, **Then** I can see standardized metrics for sensitivity, specificity, and clinical accuracy.

---

### User Story 3 - Understand AI Limitations and Risks (Priority: P3)

As a medical researcher, I want to understand the limitations, failures, and potential biases of AI diagnostic systems so that I can critically evaluate their clinical utility and safety.

**Why this priority**: This addresses the essential requirement for understanding both the benefits and risks of AI in diagnostic medicine.

**Independent Test**: Can be fully tested by accessing information about AI failures, biases, and limitations. Delivers critical safety and ethical information.

**Acceptance Scenarios**:

1. **Given** I am researching an AI diagnostic system, **When** I look for information about its limitations, **Then** I can find documented cases of AI failures, bias, or underperformance.
2. **Given** I am evaluating dataset shift concerns, **When** I access generalizability information, **Then** I can understand how well the AI system performs across different populations and settings.

---

### Edge Cases

- What happens when AI diagnostic systems encounter samples outside their training distribution?
- How does the system handle conflicting evidence between AI predictions and human expertise?
- What happens when AI system validation data is incomplete or outdated?
- How does the system address potential algorithmic bias across different demographic groups?
- What happens when regulatory approval status changes?

## Requirements *(mandatory)*

### Functional Requirements

- **FR-001**: System MUST provide access to peer-reviewed medical literature on AI applications in diagnostic laboratories
- **FR-002**: System MUST include information about regulatory approval status (FDA, CE, WHO) for AI diagnostic systems
- **FR-003**: System MUST present standardized metrics for AI diagnostic accuracy (sensitivity, specificity, ROC-AUC, PPV/NPV)
- **FR-004**: System MUST include documented cases of AI failures, bias, or underperformance in diagnostic settings
- **FR-005**: System MUST provide information about dataset bias, overfitting, and generalizability concerns
- **FR-006**: System MUST offer content organized by diagnostic specialty (hematology, pathology, microbiology, clinical chemistry)
- **FR-007**: System MUST include information about pre-analytical, analytical, and post-analytical AI applications
- **FR-008**: System MUST provide evidence-based information about clinical efficiency improvements (turnaround time, workload reduction)
- **FR-009**: System MUST include information about cost-effectiveness of AI diagnostic implementations
- **FR-010**: System MUST present both benefits and risks of AI diagnostic systems in balanced fashion

### Key Entities *(include if feature involves data)*

- **AI Diagnostic System**: Represents an AI application used in diagnostic laboratories with validation status, accuracy metrics, and clinical applications
- **Validation Study**: Contains peer-reviewed research or regulatory approval data for AI diagnostic systems including methodology and results
- **Clinical Application**: Represents specific use cases for AI in diagnostic laboratories organized by specialty and workflow stage
- **Regulatory Approval**: Documents the regulatory status of AI diagnostic systems across different jurisdictions (FDA, CE, WHO)
- **Bias Assessment**: Contains information about algorithmic bias, dataset limitations, and generalizability concerns

## Success Criteria *(mandatory)*

### Measurable Outcomes

- **SC-001**: 95% of AI diagnostic systems presented include validated accuracy metrics (sensitivity, specificity) from peer-reviewed studies
- **SC-002**: 90% of content includes information about regulatory approval status for relevant jurisdictions
- **SC-003**: Users can access information about both benefits and risks of AI systems with balanced presentation (no more than 60% benefit-focused content)
- **SC-004**: Content covers all major diagnostic specialties (hematology, pathology, microbiology, clinical chemistry) with equal depth
- **SC-005**: 85% of users report that the information helps them make informed decisions about AI implementation
- **SC-006**: Content includes information about at least 30% of documented AI failures or limitations in diagnostic settings
- **SC-007**: Users can complete a comprehensive evaluation of an AI diagnostic system's suitability for their laboratory within 30 minutes
- **SC-008**: 90% of content meets APA citation standards with primary sources from peer-reviewed medical journals